Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. - Yusuf,S.; Sleight,P.; Pogue,J.; Bosch,J.; Davies,R.; Dagenais,G. (N Engl J Med 2000; 342: 145 - 153; Erratum in N Engl J Med 2000; 342: 1376 and N Engl J Med, 2000)